SEC Form 4 · accession 0001127602-17-006681
Alkermes plc. · ALKS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elliot Ehrich
Officer — EVP, R&D & CMO, Alkermes, Inc.
Period of report
Feb 15, 2017
Accepted (ET)
Feb 16, 2017 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 15, 2017 | S | 1,000 | $58.17 | D | 49,657 | D | |
| Ordinary Shares | Feb 16, 2017 | M | 10,000 | $16.55 | A | 59,657 | D | |
| Ordinary SharesF3 | Feb 16, 2017 | S | 3,915 | $56.0454 | D | 55,742 | D | |
| Ordinary SharesF4 | Feb 16, 2017 | S | 6,085 | $56.8371 | D | 49,657 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F5 | $16.55 | Feb 16, 2017 | M | 10,000 | D | — | May 21, 2022 | Ordinary Shares | 10,000 | 29,801 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.56 to $56.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.56 to $57.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F5These options are fully vested in accordance with their terms.